Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Medicine|September 7, 2019
Tacrolimus-induced diabetic ketoacidosis with subsequent rapid recovery of endogenous insulin secretion after cessation of tacrolimus: A case report with review of literatureKoji Maruyama, Daisuke ChujoJournal of Diabetes Investigation|December 7, 2018
Response to "Preserved" glucagon secretion in fulminant type 1 diabetesNobuyuki Takahashi, Daisuke ChujoEndocrinology, Diabetes & Metabolism|March 1, 2019
Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetesMie Tonoike, Daisuke Chujo, Mitsuhiko NodaJournal of Diabetes Investigation|October 6, 2018
Contribution of pancreatic α-cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetesNobuyuki Takahashi, Daisuke Chujo, Hiroshi Kajio, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 30, 2018
Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm StudyMaya Matsushita, Daisuke Chujo, Mie Tonoike, et al.Journal of Diabetes Investigation|March 8, 2017
High risk of renal dysfunction in patients with fulminant type 1 diabetesNobuyuki Takahashi, Tetsuro Tsujimoto, Daisuke Chujo, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 25, 2020
Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm StudyKeisuke Ueno, Daisuke Chujo, Nobuyuki Takahashi, et al.Plos One|February 8, 2013
ZnT8-Specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adultsDaisuke Chujo, Emile Foucat, Thien-Son Nguyen, et al.Internal Medicine (Tokyo, Japan)|October 23, 2004
Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetesYuko Murase, Kunimasa Yagi, Masako Sugihara, et al.Diabetology International|October 2, 2023
In vivo relationship between bound and free insulin in patients with diabetes having anti-insulin antibodiesHiroyuki Asaka, Shigehiro Karashima, Daisuke Chujo, et al.Pageof 10